ReviewCurrent neuropharmacology2026

Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis Treatment.

Monica Margoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.